Abraxane nab-paclitaxel regulatory update

Celgene's Celgene International S.a.r.l. subsidiary said Swissmedic approved Abraxane nab-paclitaxel to treat metastatic pancreatic cancer in combination with gemcitabine and metastatic breast cancer....